_id

69105e80ccc777a4e85d5925

Ticker

DYAI

Name

Dyadic International Inc

Exchange

NASDAQ

Address

1044 North U.S. Highway One, Jupiter, FL, United States, 33477-5094

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.dyadic.com

Description

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and large-scale manufacture of cost-effective enzymes, proteins, metabolites, and other biologic products for life sciences, food and nutrition, and bioindustrial applications. In addition, it develops DYAI-100, a C1-SARS-CoV-2 recombinant protein RBD vaccine candidate and first C1, which is in phase 1 clinical trial to produce protein tested in humans. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa's Rubic One Health; joint development agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Last Close

0.9236

Volume

96518

Current Price

0.9106

Change

-1.407535729753141

Last Updated

2025-11-29T12:29:02.470Z

Image

data:image/webp;base64,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

Ipo Date

2004-11-05T00:00:00.000Z

Market Cap

32749958

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9995

Sentiment Sources

2

Rating

4

Target Price

5.6667

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

1164617

Cost Of Revenue

254753

Gross Profit

909864

Operating Expenses

2835233

Operating Income

-1925369

Interest Expense

85934

Pretax Income

-1976012

Net Income

-1976012

Eps

-0.05726321182652018

Dividends Per Share

-

Shares Outstanding

36187798

Income Tax Expense

-

EBITDA

-1890078

Operating Margin

-165.32207584124222

Total Other Income Expense Net

-50643

Cash

7155788

Short Term Investments

3098840

Receivables

950691

Inventories

-

Total Current Assets

11545262

Property Plant Equipment

52401

Total Assets

11672757

Payables

705834

Short Term Debt

48927

Long Term Debt

5013451

Total Liabilities

9065423

Equity

2607334

Depreciation

-26515

Change In Working Capital

-69014

Cash From Operations

-1852364

Capital Expenditures

4

Cash From Investing

93442

Cash From Financing

4940696

Net Change In Cash

3426505

PE

-

PB

12.05160398245871

ROE

-75.78668478990417

ROA

-16.928408601327007

FCF

-1852368

Fcf Percent

-1.5905383486588294

Piotroski FScore

1

Health Score

9

Deep Value Investing Score

2

Defensive Investing Score

5

Dividend Investing Score

1

Economic Moat Investing Score

3.8

Garp Investing Score

3

Growth Investing Score

3

Momentum Investing Score

4.5

Net Net Investing Score

1

Quality Investing Score

1

Value Investing Score

1.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

1164617

Quarters > 0 > income Statement > cost Of Revenue

254753

Quarters > 0 > income Statement > gross Profit

909864

Quarters > 0 > income Statement > operating Expenses

2835233

Quarters > 0 > income Statement > operating Income

-1925369

Quarters > 0 > income Statement > interest Expense

85934

Quarters > 0 > income Statement > pretax Income

-1976012

Quarters > 0 > income Statement > net Income

-1976012

Quarters > 0 > income Statement > eps

-0.05726321182652018

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

34507530

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-1890078

Quarters > 0 > income Statement > operating Margin

-165.32207584124222

Quarters > 0 > income Statement > total Other Income Expense Net

-50643

Quarters > 0 > balance Sheet > cash

7155788

Quarters > 0 > balance Sheet > short Term Investments

3098840

Quarters > 0 > balance Sheet > receivables

950691

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

11545262

Quarters > 0 > balance Sheet > property Plant Equipment

52401

Quarters > 0 > balance Sheet > total Assets

11672757

Quarters > 0 > balance Sheet > payables

705834

Quarters > 0 > balance Sheet > short Term Debt

48927

Quarters > 0 > balance Sheet > long Term Debt

5013451

Quarters > 0 > balance Sheet > total Liabilities

9065423

Quarters > 0 > balance Sheet > equity

2607334

Quarters > 0 > cash Flow > net Income

-1976012

Quarters > 0 > cash Flow > depreciation

-26515

Quarters > 0 > cash Flow > change In Working Capital

-69014

Quarters > 0 > cash Flow > cash From Operations

-1852364

Quarters > 0 > cash Flow > capital Expenditures

4

Quarters > 0 > cash Flow > cash From Investing

93442

Quarters > 0 > cash Flow > cash From Financing

4940696

Quarters > 0 > cash Flow > net Change In Cash

3426505

Quarters > 0 > ratios > PE

-0.05726321182652018

Quarters > 0 > ratios > PB

12.05160398245871

Quarters > 0 > ratios > ROE

-75.78668478990417

Quarters > 0 > ratios > ROA

-16.928408601327007

Quarters > 0 > ratios > FCF

-1852368

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-1.5905383486588294

Quarters > 0 > health Score

9

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

463449

Quarters > 1 > income Statement > cost Of Revenue

613591

Quarters > 1 > income Statement > gross Profit

-150142

Quarters > 1 > income Statement > operating Expenses

1578926

Quarters > 1 > income Statement > operating Income

-1729068

Quarters > 1 > income Statement > interest Expense

113833

Quarters > 1 > income Statement > pretax Income

-1793774

Quarters > 1 > income Statement > net Income

-1793774

Quarters > 1 > income Statement > eps

-0.05958921975592316

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

30102324

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-1679941

Quarters > 1 > income Statement > operating Margin

-373.08700633726687

Quarters > 1 > income Statement > total Other Income Expense Net

-64706

Quarters > 1 > balance Sheet > cash

2140899

Quarters > 1 > balance Sheet > short Term Investments

2842419

Quarters > 1 > balance Sheet > receivables

715317

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

7406739

Quarters > 1 > balance Sheet > property Plant Equipment

65961

Quarters > 1 > balance Sheet > total Assets

8138045

Quarters > 1 > balance Sheet > payables

738794

Quarters > 1 > balance Sheet > short Term Debt

57577

Quarters > 1 > balance Sheet > long Term Debt

5001141

Quarters > 1 > balance Sheet > total Liabilities

8667746

Quarters > 1 > balance Sheet > equity

-529701

Quarters > 1 > cash Flow > net Income

-1793774

Quarters > 1 > cash Flow > depreciation

-5997

Quarters > 1 > cash Flow > change In Working Capital

1301164

Quarters > 1 > cash Flow > cash From Operations

-130015

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-961620

Quarters > 1 > cash Flow > cash From Financing

0

Quarters > 1 > cash Flow > net Change In Cash

-1090511

Quarters > 1 > ratios > PE

-0.05958921975592316

Quarters > 1 > ratios > PB

-51.748394347754676

Quarters > 1 > ratios > ROE

338.638968021582

Quarters > 1 > ratios > ROA

-22.041829456583244

Quarters > 1 > ratios > FCF

-130015

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-0.2805378801119433

Quarters > 1 > health Score

31

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

183100

Quarters > 2 > income Statement > cost Of Revenue

297658

Quarters > 2 > income Statement > gross Profit

-114558

Quarters > 2 > income Statement > operating Expenses

1887917

Quarters > 2 > income Statement > operating Income

-2002475

Quarters > 2 > income Statement > interest Expense

113562

Quarters > 2 > income Statement > pretax Income

-2027579

Quarters > 2 > income Statement > net Income

-2027579

Quarters > 2 > income Statement > eps

-0.06784226343086457

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

29886665

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-1914017

Quarters > 2 > income Statement > operating Margin

-1093.6510103768433

Quarters > 2 > income Statement > total Other Income Expense Net

-25104

Quarters > 2 > balance Sheet > cash

5064941

Quarters > 2 > balance Sheet > short Term Investments

2284472

Quarters > 2 > balance Sheet > receivables

221719

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

7805212

Quarters > 2 > balance Sheet > property Plant Equipment

79229

Quarters > 2 > balance Sheet > total Assets

7894878

Quarters > 2 > balance Sheet > payables

448390

Quarters > 2 > balance Sheet > short Term Debt

55895

Quarters > 2 > balance Sheet > long Term Debt

4989109

Quarters > 2 > balance Sheet > total Liabilities

6971267

Quarters > 2 > balance Sheet > equity

923611

Quarters > 2 > cash Flow > net Income

-2027579

Quarters > 2 > cash Flow > depreciation

11762

Quarters > 2 > cash Flow > change In Working Capital

-156017

Quarters > 2 > cash Flow > cash From Operations

-1949731

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

482104

Quarters > 2 > cash Flow > cash From Financing

24249

Quarters > 2 > cash Flow > net Change In Cash

-1441809

Quarters > 2 > ratios > PE

-0.06784226343086457

Quarters > 2 > ratios > PB

29.465648578243435

Quarters > 2 > ratios > ROE

-219.52737678524832

Quarters > 2 > ratios > ROA

-25.682208135451873

Quarters > 2 > ratios > FCF

-1949731

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-10.648448935008192

Quarters > 2 > health Score

9

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

817376

Quarters > 3 > income Statement > cost Of Revenue

352819

Quarters > 3 > income Statement > gross Profit

464557

Quarters > 3 > income Statement > operating Expenses

1994616

Quarters > 3 > income Statement > operating Income

-1530059

Quarters > 3 > income Statement > interest Expense

126233

Quarters > 3 > income Statement > pretax Income

-1550880

Quarters > 3 > income Statement > net Income

-1550880

Quarters > 3 > income Statement > eps

-0.05289833868286861

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

29318123

Quarters > 3 > income Statement > income Tax Expense

43277

Quarters > 3 > income Statement > EBITDA

-1424645

Quarters > 3 > income Statement > operating Margin

-187.1915740124496

Quarters > 3 > income Statement > total Other Income Expense Net

-20821

Quarters > 3 > balance Sheet > cash

6506750

Quarters > 3 > balance Sheet > short Term Investments

2756577

Quarters > 3 > balance Sheet > receivables

237027

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

9827668

Quarters > 3 > balance Sheet > property Plant Equipment

92211

Quarters > 3 > balance Sheet > total Assets

9930275

Quarters > 3 > balance Sheet > payables

482320

Quarters > 3 > balance Sheet > short Term Debt

54249

Quarters > 3 > balance Sheet > long Term Debt

4977347

Quarters > 3 > balance Sheet > total Liabilities

7459985

Quarters > 3 > balance Sheet > equity

2470290

Quarters > 3 > cash Flow > net Income

-1550880

Quarters > 3 > cash Flow > depreciation

4572

Quarters > 3 > cash Flow > change In Working Capital

571120

Quarters > 3 > cash Flow > cash From Operations

-696395

Quarters > 3 > cash Flow > capital Expenditures

5

Quarters > 3 > cash Flow > cash From Investing

1263275

Quarters > 3 > cash Flow > cash From Financing

24251

Quarters > 3 > cash Flow > net Change In Cash

585136

Quarters > 3 > ratios > PE

-0.05289833868286861

Quarters > 3 > ratios > PB

10.807266678730027

Quarters > 3 > ratios > ROE

-62.78129288464107

Quarters > 3 > ratios > ROA

-15.617694374022875

Quarters > 3 > ratios > FCF

-696400

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.8519946756449908

Quarters > 3 > health Score

9

Valuation > metrics > PE

-0.05726321182652018

Valuation > metrics > PB

12.05160398245871

Valuation > final Score

20

Valuation > verdict

301.7% Overvalued

Profitability > metrics > ROE

-75.78668478990417

Profitability > metrics > ROA

-17.115350002451223

Profitability > metrics > Net Margin

-1.6967054405010402

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

3.4768936392499006

Risk > metrics > Interest Coverage

-22.40520632113017

Risk > final Score

-84

Risk > verdict

High

Liquidity > metrics > Current Ratio

15.296579976972843

Liquidity > metrics > Quick Ratio

15.296579976972843

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

40

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-31

Prev Risks > 1

-65

Prev Risks > 2

-42

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:24:34.588Z